{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:33:59Z","timestamp":1788910439090,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T00:00:00Z","timestamp":1324944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00702-011-0753-z","type":"journal-article","created":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T08:57:50Z","timestamp":1324889870000},"page":"685-691","source":"Crossref","is-referenced-by-count":21,"title":["Neuromelanin enhances the toxicity of \u03b1-synuclein in SK-N-SH cells"],"prefix":"10.1007","volume":"119","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benshu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,27]]},"reference":[{"key":"753_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2202-11-41","volume":"11","author":"M Bisaglia","year":"2010","unstructured":"Bisaglia M, Greggio E, Maric D, Miller DW, Cookson MR, Bubacco L (2010) Alpha-synuclein overexpression increases dopamine toxicity in BE2\u2013M17 cells. BMC Neurosci 11:41","journal-title":"BMC Neurosci"},{"key":"753_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"753_CR3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","volume":"28","author":"L Chen","year":"2008","unstructured":"Chen L, Ding Y, Cagniard B, Van Laar AD, Mortimer A, Chi W, Hastings TG, Kang UJ, Zhuang X (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 28:425\u2013433","journal-title":"J Neurosci"},{"key":"753_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0896-6273(02)00780-8","volume":"35","author":"T Dawson","year":"2002","unstructured":"Dawson T, Mandir A, Lee M (2002) Animal models of PD: pieces of the same puzzle? Neuron 35:219\u2013222","journal-title":"Neuron"},{"key":"753_CR5","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1046\/j.1471-4159.2000.0752583.x","volume":"75","author":"KL Double","year":"2000","unstructured":"Double KL, Zecca L, Costi P, Mauer M, Griesinger C, Ito S, Ben-Shachar D, Bringmann G, Fariello RG, Riederer P, Gerlach M (2000) Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins. J Neurochem 75:2583\u20132589","journal-title":"J Neurochem"},{"key":"753_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0006-2952(03)00293-4","volume":"66","author":"KL Double","year":"2003","unstructured":"Double KL, Gerlach M, Schunemann V, Trautwein AX, Zecca L, Gallorini M, Youdim MB, Riederer P, Ben-Shachar D (2003) Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem Pharmacol 66:489\u2013494","journal-title":"Biochem Pharmacol"},{"key":"753_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0197-0186(02)00161-4","volume":"42","author":"M Fasano","year":"2003","unstructured":"Fasano M, Giraudo S, Coha S, Bergamasco B, Lopiano L (2003) Residual substantia nigra neuromelanin in Parkinson\u2019s disease is cross-linked to alpha-synuclein. Neurochem Int 42:603\u2013606","journal-title":"Neurochem Int"},{"key":"753_CR8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1046\/j.1471-4159.2003.01923.x","volume":"86","author":"BA Faucheux","year":"2003","unstructured":"Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC (2003) Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson\u2019s disease. J Neurochem 86:1142\u20131148","journal-title":"J Neurochem"},{"issue":"Pt 5","key":"753_CR9","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283\u20132301","journal-title":"Brain"},{"issue":"Suppl 2","key":"753_CR10","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.parkreldis.2008.04.028","volume":"14","author":"M Gerlach","year":"2008","unstructured":"Gerlach M, Riederer P, Double KL (2008) Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson\u2019s disease. Parkinsonism Relat Disord 14(Suppl 2):S185\u2013S188","journal-title":"Parkinsonism Relat Disord"},{"key":"753_CR11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1098\/rstb.2000.0767","volume":"356","author":"M Goedert","year":"2001","unstructured":"Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA (2001) From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. Philos Trans R Soc Lond B Biol Sci 356:213\u2013227","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"753_CR12","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awh584","volume":"128","author":"GM Halliday","year":"2005","unstructured":"Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL (2005) Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson\u2019s disease. Brain 128:2654\u20132664","journal-title":"Brain"},{"key":"753_CR13","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/brain\/awf251","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease. Brain 125:2431\u20132445","journal-title":"Brain"},{"key":"753_CR14","doi-asserted-by":"crossref","first-page":"11465","DOI":"10.1074\/jbc.M111428200","volume":"277","author":"M Hashimoto","year":"2002","unstructured":"Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E (2002) Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem 277:11465\u201311472","journal-title":"J Biol Chem"},{"key":"753_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.abb.2003.08.015","volume":"418","author":"ML Hegde","year":"2003","unstructured":"Hegde ML, Jagannatha Rao KS (2003) Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson\u2019s disease. Arch Biochem Biophys 418:169\u2013178","journal-title":"Arch Biochem Biophys"},{"key":"753_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334:345\u2013348","journal-title":"Nature"},{"key":"753_CR17","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.neurobiolaging.2006.07.017","volume":"28","author":"H Jiang","year":"2007","unstructured":"Jiang H, Wu YC, Nakamura M, Liang Y, Tanaka Y, Holmes S, Dawson VL, Dawson TM, Ross CA, Smith WW (2007) Parkinson\u2019s disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death. Neurobiol Aging 28:1709\u20131717","journal-title":"Neurobiol Aging"},{"key":"753_CR18","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","volume":"59","author":"A Kastner","year":"1992","unstructured":"Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y (1992) Is the vulnerability of neurons in the substantia nigra of patients with Parkinson\u2019s disease related to their neuromelanin content? J Neurochem 59:1080\u20131089","journal-title":"J Neurochem"},{"key":"753_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3940(99)00740-5","volume":"275","author":"NG Kholodilov","year":"1999","unstructured":"Kholodilov NG, Oo TF, Burke RE (1999) Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine. Neurosci Lett 275:105\u2013108","journal-title":"Neurosci Lett"},{"key":"753_CR20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"753_CR21","doi-asserted-by":"crossref","first-page":"e11464","DOI":"10.1371\/journal.pone.0011464","volume":"5","author":"A Kurz","year":"2010","unstructured":"Kurz A, Double KL, Lastres-Becker I, Tozzi A, Tantucci M, Bockhart V, Bonin M, Garcia-Arencibia M, Nuber S, Schlaudraff F, Liss B, Fernandez-Ruiz J, Gerlach M, Wullner U, Luddens H, Calabresi P, Auburger G, Gispert S (2010) A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS One 5:e11464","journal-title":"PLoS One"},{"key":"753_CR22","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1471-4159.2001.00149.x","volume":"76","author":"M Lee","year":"2001","unstructured":"Lee M, Hyun D, Halliwell B, Jenner P (2001) Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J Neurochem 76:998\u20131009","journal-title":"J Neurochem"},{"key":"753_CR23","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11064-009-9986-8","volume":"34","author":"SL Leong","year":"2009","unstructured":"Leong SL, Cappai R, Barnham KJ, Pham CL (2009) Modulation of alpha-synuclein aggregation by dopamine: a review. Neurochem Res 34:1838\u20131846","journal-title":"Neurochem Res"},{"key":"753_CR24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1471-4159.2005.03404.x","volume":"95","author":"J Li","year":"2005","unstructured":"Li J, Scheller C, Koutsilieri E, Griffiths F, Beart PM, Mercer LD, Halliday G, Kettle E, Rowe D, Riederer P, Gerlach M, Rodriguez M, Double KL (2005) Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells. J Neurochem 95:599\u2013608","journal-title":"J Neurochem"},{"key":"753_CR25","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","volume":"99","author":"C Lo Bianco","year":"2002","unstructured":"Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P (2002) Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 99:10813\u201310818","journal-title":"Proc Natl Acad Sci USA"},{"key":"753_CR26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2007.11.075","volume":"365","author":"CE Moussa","year":"2008","unstructured":"Moussa CE, Mahmoodian F, Tomita Y, Sidhu A (2008) Dopamine differentially induces aggregation of A53T mutant and wild type alpha-synuclein: insights into the protein chemistry of Parkinson\u2019s disease. Biochem Biophys Res Commun 365:833\u2013839","journal-title":"Biochem Biophys Res Commun"},{"key":"753_CR27","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.biocel.2009.05.008","volume":"41","author":"MS Parihar","year":"2009","unstructured":"Parihar MS, Parihar A, Fujita M, Hashimoto M, Ghafourifar P (2009) Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int J Biochem Cell Biol 41:2015\u20132024","journal-title":"Int J Biochem Cell Biol"},{"key":"753_CR28","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"753_CR29","first-page":"139","volume":"26","author":"RC Schwyn","year":"1970","unstructured":"Schwyn RC, King JS, Fox CA (1970) Pigments in the red nucleus and substantia nigra in man and in representative old and new world monkeys. Bol Estud Med Biol 26:139\u2013160","journal-title":"Bol Estud Med Biol"},{"key":"753_CR30","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","volume":"9","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Orth M, Wilkinson JM, Taanman JW, Warner TT, Cooper JM, Schapira AH (2000) Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum Mol Genet 9:2683\u20132689","journal-title":"Hum Mol Genet"},{"key":"753_CR31","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1074\/mcp.M900006-MCP200","volume":"8","author":"F Tribl","year":"2009","unstructured":"Tribl F, Asan E, Arzberger T, Tatschner T, Langenfeld E, Meyer HE, Bringmann G, Riederer P, Gerlach M, Marcus K (2009) Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach. Mol Cell Proteomics 8:1832\u20131838","journal-title":"Mol Cell Proteomics"},{"key":"753_CR32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0891-5849(01)00513-5","volume":"30","author":"S Turnbull","year":"2001","unstructured":"Turnbull S, Tabner BJ, El-Agnaf OM, Moore S, Davies Y, Allsop D (2001) Alpha-synuclein implicated in Parkinson\u2019s disease catalyses the formation of hydrogen peroxide in vitro. Free Radic Biol Med 30:1163\u20131170","journal-title":"Free Radic Biol Med"},{"key":"753_CR33","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson\u2019s disease and heavy metal exposure. J Biol Chem 276:44284\u201344296","journal-title":"J Biol Chem"},{"key":"753_CR34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","volume":"8","author":"J Xu","year":"2002","unstructured":"Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8:600\u2013606","journal-title":"Nat Med"},{"key":"753_CR35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173","journal-title":"Ann Neurol"},{"key":"753_CR36","doi-asserted-by":"crossref","unstructured":"Zecca L, Zucca FA, Costi P, Tampellini D, Gatti A, Gerlach M, Riederer P, Fariello RG, Ito S, Gallorini M and Sulzer D (2003) The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour. J Neural Transm Suppl 65:145\u2013155","DOI":"10.1007\/978-3-7091-0643-3_8"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0753-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-011-0753-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0753-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:30:18Z","timestamp":1559089818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0753-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,27]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0753-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,27]]}}}